We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+6.11%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
–
AUM
$601M
AUM Growth
+$28M
Cap. Flow
-$2.62M
Cap. Flow %
-0.44%
Top 10 Hldgs %
32.96%
Holding
261
New
–
Increased
–
Reduced
1
Closed
3

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TRI icon
Thomson Reuters
TRI
+$2.06M
2
ANDV
Andeavor
ANDV
+$329K
3
ECON icon
Columbia Emerging Markets Consumer ETF
ECON
+$233K
4
AEG icon
Aegon
AEG
+$3.39K

Sector Composition

Rank Sector Weight
1 Financials 11.82%
2 Healthcare 10.28%
3 Technology 9.9%
4 Consumer Discretionary 7.65%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AES icon
26
AES
AES
$10.6B
$4.07M 0.68%
290,617
– –
COF icon
27
Capital One
COF
$124B
$4.04M 0.67%
42,503
– –
LLY icon
28
Eli Lilly
LLY
$1.07T
$4M 0.67%
37,284
– –
ESRX
29
DELISTED
Express Scripts Holding Company
ESRX
$3.7M 0.62%
38,952
– –
WFC icon
30
Wells Fargo
WFC
$261B
$3.66M 0.61%
69,664
– –
DISCK
31
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$3.61M 0.6%
122,176
– –
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$3.59M 0.6%
12,356
– –
OXY icon
33
Occidental Petroleum
OXY
$57B
$3.56M 0.59%
43,336
– –
PG icon
34
Procter & Gamble
PG
$343B
$3.53M 0.59%
42,414
– –
UAL icon
35
United Airlines
UAL
$38.4B
$3.51M 0.58%
39,454
– –
CVS icon
36
CVS Health
CVS
$137B
$3.48M 0.58%
44,265
– –
AZN icon
37
AstraZeneca
AZN
$263B
$3.44M 0.57%
43,455
– –
LEN icon
38
Lennar Class A
LEN
$20.4B
$3.4M 0.57%
75,200
– –
MO icon
39
Altria Group
MO
$122B
$3.35M 0.56%
55,516
– –
LYB icon
40
LyondellBasell Industries
LYB
$19.5B
$3.32M 0.55%
32,424
– –
JNJ icon
41
Johnson & Johnson
JNJ
$635B
$3.31M 0.55%
23,927
– –
ADBE icon
42
Adobe
ADBE
$89.5B
$3.26M 0.54%
12,092
– –
GILD icon
43
Gilead Sciences
GILD
$161B
$3.25M 0.54%
42,026
– –
VIAB
44
DELISTED
Viacom Inc. Class B
VIAB
$3.24M 0.54%
96,032
– –
FLR icon
45
Fluor
FLR
$7.29B
$3.24M 0.54%
55,741
– –
D icon
46
Dominion Energy
D
$62.5B
$3.2M 0.53%
45,546
– –
MDT icon
47
Medtronic
MDT
$107B
$3.14M 0.52%
31,898
– –
KMB icon
48
Kimberly-Clark
KMB
$36.4B
$3.1M 0.52%
27,321
– –
T icon
49
AT&T
T
$165B
$3.1M 0.52%
122,303
– –
CELG
50
DELISTED
Celgene Corp
CELG
$3.08M 0.51%
34,446
– –
1
2
3 4 5

Similar funds

SIM
Sadoff Investment Management Milwaukee, Wisconsin $1.28B AUM 6.95% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
MCM
Maryland Capital Management Towson, Maryland $1.2B AUM 18.21% 1-Year Est. Return
ACP
Ashfield Capital Partners San Francisco, California $1.19B AUM 14.56% 1-Year Est. Return
DWM
Doyle Wealth Management St. Petersburg, Florida $1.16B AUM 9.32% 1-Year Est. Return
H6H
Hightower 6M Holding Wichita, Kansas $1.11B AUM

Corient Capital Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Corient Capital Partners held 261 positions worth $601M, up 4.9% from $573M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 1.1%. Corient Capital Partners opened no new positions and exited 3, leaving the 261-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Technology.

  • Corient Capital Partners's biggest Q3 2018 reduction was Aegon, cutting an estimated $3.39K.
  • Corient Capital Partners fully exited Thomson Reuters in Q3 2018, selling an estimated $2.06M.
  • Corient Capital Partners's ten largest holdings make up 33% of its $601M portfolio in Q3 2018.
  • Corient Capital Partners opened 0 new positions and closed 3 in Q3 2018.
  • Corient Capital Partners's portfolio value rose 4.9% quarter-over-quarter to $601M.

Based on Corient Capital Partners's 13F filing for Q3 2018, filed 15 Nov 2018.